New York based Genadyne Biotechnologies Inc., is promoting negative–pressure wound therapy, non-powered and powered pressure reliving therapeutic surfaces, wireless telemedicine solutions, and more to promote wound healing where traditional approaches fail to make any headway.
The good news, according to doctors, is indications for negative pressure wound therapy (NPWT) are expanding to include infected wounds and complicated wounds with exposed bone tendon, or those caused due to orthopedic hardware.
Negative pressure wound therapy, also known as vacuum assisted closure (VAC) therapy, was developed more than 25 years back. It involves the application of subatomic pressure to a wound through a pressure pump attached to a vacuum sponge with an adhesive dressing.
Genadyne Biotechnologies founded by Shahzad Pirzada is providing a stimulus for this Negative pressure wound therapy and more with an array of innovative products.
This therapy has recorded widespread success among diabetic patients with microcirculatory pathology.
In fact, some reports say, by reducing tissue edema, and thereby reducing the circumference of the extremity and the surface area of the wound negative pressure wound therapy is revolutionizing how physicians can treat wounds with exposed bone tendon, or those caused due to orthopedic hardware.
This therapy nevertheless is with a caveat. According to specialists, the wound healing may not follow a simple path, as some acute wounds may fail to heal and some may become chronic.
Yet, this revolutionary system of healing has potential.
“Unlike many other wound treatments and dressings, it has good evidence base to demonstrate its effectiveness. Further, patient selections must be made in a careful manner by considering a range of factors, and practitioners of NPWT must be trained to use specific devices”.
With the introduction of NPWT in community settings showing promise, patients with chronic and complex wounds can now be treated at home, which also facilitates early discharge.
Now Shahzad Pirzada’s Genadyne Biotechnologies and The MED Group have come to an understanding on a Group Purchasing Agreement in which Genadyne will provide their negative pressure wound therapy to Home Care Members who are MED members.
The MED Group is a Group Purchasing and Business Solutions Organization that helps Home Medical Equipment Providers lower their medical costs for home medical equipment, healthcare, technology, and other supplies – from cell phones to office supplies and everything in between.
The Group is a wholly owned subsidiary of Managed Healthcare Associates, Inc. (MHA).
Shahzad Pirzada’s Genadyne apart from developing NPWT also focuses on powered and non-powered pressure relieving therapeutic devices, wireless telemedicine systems, and wireless and wired weight-scale systems.
For those unfamiliar, wireless telemedicine systems is an emerging type of information infrastructure that has the potential of supporting an array of advanced services for healthcare.
About Shahzad Pirzada
Shahzad Pirzada has 14 years of experience in developing and bringing to the market a wide array of respiratory products – primarily CPAP and BIPAP technologies and portable oxygen delivering systems. Shahzad’s flagship venture is Genadyne Biotechnologies Inc., an international company with distributors spread across North America and Europe.
For more information about Genadyne Biotechnologies Inc., visit http://www.genadyne.com/ Or call 1-800-208-2025
Company Name: Genadyne Biotechnologies Inc.
Contact Person: Shahzad Pirzada
Email:Send Email
Phone: 1-800-208-2025
Country: United States
Website: http://www.genadyne.com
Source: www.abnewswire.com
0 comments:
Post a Comment